Lineage Cell Therapeutics (LCTX) Gross Margin Growth (3y) (2014 - 2026)
Lineage Cell Therapeutics (LCTX) Gross Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 722.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -191.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -162.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -91.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn | 499.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 499.00 |
| Dec 31, 2025 | 433.00 |
| Sep 30, 2025 | 770.00 |
| Jun 30, 2025 | 331.00 |
| Mar 31, 2025 | 96.00 |
| Dec 31, 2024 | 9,270.00 |
| Sep 30, 2024 | 4,239.00 |
| Jun 30, 2024 | 2,129.00 |
| Mar 31, 2024 | 2,186.00 |
| Dec 31, 2023 | 1,985.00 |
| Sep 30, 2023 | 430.00 |
| Jun 30, 2023 | 1,549.00 |
| Mar 31, 2023 | 1,330.00 |
| Dec 31, 2022 | 458.00 |
| Sep 30, 2022 | 1,227.00 |
| Jun 30, 2022 | 901.00 |
| Mar 31, 2022 | 397.00 |
| Dec 31, 2021 | -9,121.00 |
| Sep 30, 2021 | -3,983.00 |
| Jun 30, 2021 | -2,025.00 |